|
시장보고서
상품코드
1422742
세계의 뇌졸중 후처리 소프트웨어 시장 예측(-2030년)Stroke Post Processing Software Market Research Report Forecast till 2030 |
||||||
뇌졸중 후처리 소프트웨어 시장 규모는 예측 기간 동안 연평균 8.64%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
뇌졸중 후처리 소프트웨어 시장은 뇌졸중 발생률 증가, 첨단 영상 기술 혁신, 편리하고 정확한 분석에 대한 관심 증가 등을 배경으로 크게 성장할 수 있는 여건을 갖추고 있습니다.
지역별로는 북미가 2022년 가장 큰 점유율을 차지할 것으로 보입니다. 여기에는 의료 서비스 기반 구축, 기계 발전, 많은 사업자의 진입 등이 포함됩니다. 반면, 아시아태평양은 예측 기간 동안 가장 큰 성장을 보일 것으로 예상됩니다. 이는 영상 처리의 발전, R&D의 자산 확대, 뇌졸중 증가에 기인합니다.
세계 뇌졸중 후처리 소프트웨어 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 세계의 뇌졸중 포스트프로세스 소프트웨어 시장 : 인스톨별
- 개요
- 데스크톱
- 휴대폰 및 태블릿
제5장 세계의 뇌졸중 포스트프로세스 소프트웨어 시장 : 모달리티별
- 개요
- MRI
- CT 스캔
제6장 세계의 뇌졸중 포스트프로세스 소프트웨어 시장 : 유형별
- 개요
- 허혈성 뇌졸중
- 출혈성 뇌졸중
- 기타
제7장 세계의 뇌졸중 포스트프로세스 소프트웨어 시장 : 최종사용자별
- 개요
- 병원 및 클리닉
- 전문센터
- 기타
제8장 세계의 뇌졸중 포스트프로세스 소프트웨어 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제9장 경쟁 구도
- 개요
- 경쟁 벤치마킹
- 주요 성장 전략
- 개발수 주요 기업
- 주요 개발 분석
- 주요 발전과 성장 전략
- 주요 기업 재무 상황
제10장 기업 개요
- GE HEALTHCARE
- SIEMENS HEALTHINEERS
- VIZ.AI, INC.
- NICOLAB B.V.
- TERARECON, INC
- BRAINOMIX
- CANON MEDICAL INFORMATICS, INC.
- KONINKLIJKE PHILIPS N.V.
- ICOMETRIX
- RAPIDAI
제11장 부록
LSH 24.02.21Market Overview
The Stroke Post Processing Software Market is expected to register a CAGR of 8.64% during the review period.
The stroke post processing software market is ready for significant development driven by expanding stroke rates, high level imaging innovations, developing accentuation on convenient and precise analysis. As medical services suppliers focus on productive examination of clinical pictures for worked on quiet results, the market is supposed to observe persistent extension, offering refined arrangements in the field of neuroimaging.
The development of the stroke post processing software market is credited to the rising predominance of strokes, developing mindfulness among patients, and rising number of key drives.
As the quantity of strokes rises, so will the interest for stroke the board frameworks and software. Also, as per the Places for Infectious prevention and Counteraction (CDC), stroke is supposed to represent one in each six passings in the US by 2020. The utilization of stroke post-processing software empowers the improvement of additional effective pathways, quicker treatment choices, and better quiet results.
In this way, the rising number of patients with stroke is adding to the development in the worldwide market. Furthermore, a few factors like segment changes, natural circumstances, and expanding mental pressure are additionally bringing about rising stroke cases, in this manner filling the market development during the forecast time frame.
Market Segment Insights
The Stroke Post Processing Software Market segmentation, based on installation, includes desktops and mobile phone & tablets. The Stroke Post Processing Software Market segmentation, based on modality, includes MRI and CT scan.
The Stroke Post Processing Software Market segmentation, based on type, includes ischemic stroke, hemorrhagic stroke, and others. The Stroke Post Processing Software Market segmentation, based on end user, includes hospital & clinics, specialty centers, and others.
Regional Insights
The North America stroke post processing software media market represented the biggest market share in 2022. Key variables ascribed to its enormous offer incorporate created medical services foundation, expanding mechanical headway, and the presence of many market players in the region.
Europe stroke post processing software market represented the second-biggest market share because of developing predominance of ischemic stroke among people, and the rising familiarity with treatment. Moreover, the Germany stroke post processing software market is ascribed to hold the biggest market share, and the France stroke post processing software market is extended be the quickest developing market in the Europe region.
The Asia-Pacific stroke post processing software market is supposed to be the quickest developing from 2023 to 2030 because of developing headway in imaging advancements, expanding assets in research exercises, and rising commonness of strokes. Also, China stroke post processing software market accounted to hold the biggest market share, and the India stroke post processing software market is projected to be the rapid developing market in the Asia-Pacific region.
Major Players
Key Companies in the Stroke Post Processing Software market are Canon Medical Informatics, GE Healthcare (US), Siemens Healthineers (Germany), ai, Inc (US), Koninklijke Philips N.V. (Netherlands), Inc (US), TeraRecon Inc (US), Brainomix (UK), Icometrix (Belgium), Nicolab B.V. (Netherlands), and RapidAI (US).
TABLE OF CONTENTS
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
- 1.1 OVERVIEW
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
- 2.4 MARKET STRUCTURE
- 2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
- 3.1 DATA MINING
- 3.2 SECONDARY RESEARCH
- 3.3 PRIMARY RESEARCH
- 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
- 3.5 FORECASTING TECHNIQUES
- 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
- 3.7 DATA TRIANGULATION
- 3.8 VALIDATION
4 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY INSTALLATION
- 4.1 OVERVIEW
- 4.2 DESKTOPS
- 4.3 MOBILE PHONE & TABLETS
5 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY MODALITY
- 5.1 OVERVIEW
- 5.2 MRI
- 5.3 CT SCAN
6 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY TYPE
- 6.1 OVERVIEW
- 6.2 ISCHEMIC STROKE
- 6.3 HEMORRHAGIC STROKE
- 6.4 OTHERS
7 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY END USER
- 7.1 OVERVIEW
- 7.2 HOSPITAL& CLINICS
- 7.3 SPECIALTY CENTERS
- 7.4 OTHERS
8 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY REGION
- 8.1 OVERVIEW
- 8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
- 8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
- 8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 SOUTH KOREA
- 8.4.5 AUSTRALIA
- 8.4.6 REST OF ASIA-PACIFIC
- 8.5 REST OF THE WORLD
- 8.5.1 AFRICA
- 8.5.2 LATIN AMERICA
- 8.5.3 MIDDLE EAST
9 COMPETITIVE LANDSCAPE
- 9.1 OVERVIEW
- 9.2 COMPETITIVE BENCHMARKING
- 9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL STROKE POST PROCESSING SOFTWARE MARKET
- 9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL STROKE POST PROCESSING SOFTWARE MARKET
- 9.5 KEY DEVELOPMENT ANALYSIS
- 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 PRODUCT/SERVICE APPROVAL AND PRODUCT LAUNCH
- 9.6.2 PARTNERSHIP/AGREEMENT/INVESTMENT/CONTRACT/EXPANSION/ INVESTMENT
- 9.7 MAJOR PLAYERS FINANCIALS
- 9.7.1 SALES (USD MILLION), 2022
- 9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022
10 COMPANY PROFILES
- 10.1 GE HEALTHCARE
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
- 10.2 SIEMENS HEALTHINEERS
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
- 10.3 VIZ.AI, INC.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
- 10.4 NICOLAB B.V.
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 KEY STRATEGIES
- 10.5 TERARECON, INC
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 SWOT ANALYSIS
- 10.5.5 KEY DEVELOPMENTS
- 10.5.6 KEY STRATEGIES
- 10.6 BRAINOMIX
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 SERVICES OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.6.6 KEY STRATEGIES
- 10.7 CANON MEDICAL INFORMATICS, INC.
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 SERVICES OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 KEY STRATEGIES
- 10.8 KONINKLIJKE PHILIPS N.V.
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES
- 10.9 ICOMETRIX
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
- 10.10 RAPIDAI
- 10.10.1 COMPANY OVERVIEWS
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES
11 APPENDIX
- 11.1 REFERENCES
- 11.2 RELATED REPORTS
